对宿主免疫应对肺囊虫的认识的新进展。
New advances in understanding the host immune response to Pneumocystis.
机构信息
Institute of Infectious Disease and Molecular Medicine (IDM), Department of Pathology, Faculty of Health Sciences, University of Cape Town, South Africa.
Center for Translational Research in Infection and Inflammation, Tulane School of Medicine, New Orleans, USA.
出版信息
Curr Opin Microbiol. 2017 Dec;40:65-71. doi: 10.1016/j.mib.2017.10.019. Epub 2017 Nov 12.
Abstract
Pneumocystis jirovecii causes clinical pneumonia in immunocompromised hosts. Despite this, the inability to cultivate this organism in vitro has likely hindered the field in ascertaining the true impact of Pneumocystis in human infection. However the recent release of the genome as well as in advances in understanding host genetics, and other risk factors for infection and robust experimental models of disease have shed new light on the impact of this fungal pathogen as to better define populations at risk. This review will highlight these recent advances as well as highlight future needed areas of research.
摘要
肺孢子菌引起免疫功能低下宿主的临床肺炎。尽管如此，由于无法在体外培养这种生物体，这可能阻碍了该领域确定肺孢子菌在人类感染中的真正影响。然而，最近基因组的发布以及对宿主遗传学和其他感染风险因素的深入了解，以及疾病的强大实验模型，为这种真菌病原体的影响提供了新的认识，从而更好地确定了处于危险中的人群。本文将重点介绍这些最新进展，并强调未来需要研究的领域。
相似文献
1
New advances in understanding the host immune response to Pneumocystis.
Curr Opin Microbiol. 2017 Dec;40:65-71. doi: 10.1016/j.mib.2017.10.019. Epub 2017 Nov 12.
2
Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii.
J Eukaryot Microbiol. 2003;50 Suppl:672-3. doi: 10.1111/j.1550-7408.2003.tb00680.x.
3
Current understanding of Pneumocystis immunology.
Future Microbiol. 2010 Jan;5(1):43-65. doi: 10.2217/fmb.09.116.
4
Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review.
Parasitol Res. 2015 Oct;114(10):3577-85. doi: 10.1007/s00436-015-4678-6. Epub 2015 Aug 19.
5
Diffusion of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis colonization: frequency and putative risk factors.
Med Mycol. 2017 Jul 1;55(5):568-572. doi: 10.1093/mmy/myw113.
6
[Pneumocystosis is an actual infection].
Zh Mikrobiol Epidemiol Immunobiol. 2012 Nov-Dec(6):115-9.
7
Coinfection of Pneumocystis jirovecii and invasive pulmonary aspergillosis in an immunocompromised patient: a diagnostic challenge.
Onkologie. 2013;36(10):582-4. doi: 10.1159/000355168. Epub 2013 Sep 16.
8
[Pneumocystis jirovecii: what does this mean?].
Rev Pneumol Clin. 2010 Dec;66(6):342-6. doi: 10.1016/j.pneumo.2009.09.007. Epub 2010 Feb 12.
9
Current State of Carbohydrate Recognition and C-Type Lectin Receptors in Innate Immunity.
Front Immunol. 2021 Dec 16;12:798214. doi: 10.3389/fimmu.2021.798214. eCollection 2021.
10
Genomic insights into the host specific adaptation of the Pneumocystis genus.
Commun Biol. 2021 Mar 8;4(1):305. doi: 10.1038/s42003-021-01799-7.
引用本文的文献
1
An Observational Analysis of a Large Cohort of Pneumonia.
Open Forum Infect Dis. 2025 Jul 3;12(7):ofaf390. doi: 10.1093/ofid/ofaf390. eCollection 2025 Jul.
2
Immune responses of different hosts to infection.
Eur Respir Rev. 2025 Jul 9;34(177). doi: 10.1183/16000617.0247-2024. Print 2025 Jul.
3
Pneumocystis Jirovecii Pneumonia in Two Immunosuppressed Non-HIV Infected Patients: A Clinical and Therapeutic Analysis.
Infect Drug Resist. 2025 Jan 15;18:285-295. doi: 10.2147/IDR.S495188. eCollection 2025.
4
Protocol for the systematic review of the Pneumocystis jirovecii-associated pneumonia in non-HIV immunocompromised patients.
PLoS One. 2024 May 9;19(5):e0302055. doi: 10.1371/journal.pone.0302055. eCollection 2024.
5
CMV Infection and Lymphopenia: Warning Markers of Pneumonia in Kidney Transplant Recipients.
Transpl Int. 2024 Jan 24;37:12192. doi: 10.3389/ti.2024.12192. eCollection 2024.
6
Immune responses to human fungal pathogens and therapeutic prospects.
Nat Rev Immunol. 2023 Jul;23(7):433-452. doi: 10.1038/s41577-022-00826-w. Epub 2023 Jan 4.
7
Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients.
Cureus. 2022 Aug 6;14(8):e27727. doi: 10.7759/cureus.27727. eCollection 2022 Aug.
8
Targeted NGS-Based Analysis of Reveals Novel Genotypes.
J Fungi (Basel). 2022 Aug 17;8(8):863. doi: 10.3390/jof8080863.
9
Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Infection.
J Immunol Res. 2022 Apr 14;2022:5187166. doi: 10.1155/2022/5187166. eCollection 2022.
10
Prevalence of Pneumocystosis in Sub-Saharan Africa and Helminth Immune Modulation.
J Fungi (Basel). 2021 Dec 31;8(1):45. doi: 10.3390/jof8010045.
本文引用的文献
1
The Trophic Life Cycle Stage of the Opportunistic Fungal Pathogen Pneumocystis murina Hinders the Ability of Dendritic Cells To Stimulate CD4 T Cell Responses.
Infect Immun. 2017 Sep 20;85(10). doi: 10.1128/IAI.00396-17. Print 2017 Oct.
2
The changing trends and profile of pneumocystosis mortality in the United States, 1999-2014.
Mycoses. 2017 Sep;60(9):607-615. doi: 10.1111/myc.12636. Epub 2017 May 31.
3
Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity.
Cell Rep. 2017 Mar 28;18(13):3078-3090. doi: 10.1016/j.celrep.2017.03.016.
4
Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii.
Infect Immun. 2017 Mar 23;85(4). doi: 10.1128/IAI.00850-16. Print 2017 Apr.
5
Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia.
Infect Immun. 2017 Feb 23;85(3). doi: 10.1128/IAI.00939-16. Print 2017 Mar.
6
Intermittent Courses of Corticosteroids Also Present a Risk for Pneumonia in Non-HIV Patients.
Can Respir J. 2016;2016:2464791. doi: 10.1155/2016/2464791. Epub 2016 Sep 18.
7
Pneumocystis infection alters the activation state of pulmonary macrophages.
Immunobiology. 2017 Feb;222(2):188-197. doi: 10.1016/j.imbio.2016.10.003. Epub 2016 Oct 5.
8
The life cycle stages of Pneumocystis murina have opposing effects on the immune response to this opportunistic, fungal pathogen.
Infect Immun. 2016 Nov;84(11):3195-3205. doi: 10.1128/IAI.00519-16. Epub 2016 Aug 29.
9
β-Glucans Are Masked but Contribute to Pulmonary Inflammation During Pneumocystis Pneumonia.
J Infect Dis. 2016 Sep 1;214(5):782-91. doi: 10.1093/infdis/jiw249. Epub 2016 Jun 19.
10
CD4(+) T-Cell-Independent Secondary Immune Responses to Pneumocystis Pneumonia.
Front Immunol. 2016 May 11;7:178. doi: 10.3389/fimmu.2016.00178. eCollection 2016.
Zotero 插件